EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
De novo mutations in epileptic encephalopathies.
|
23934111 |
2013 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.
|
26950270 |
2016 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
De novo mutations in moderate or severe intellectual disability.
|
25356899 |
2014 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis.
|
26993267 |
2016 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Diagnostic Targeted Resequencing in 349 Patients with Drug-Resistant Pediatric Epilepsies Identifies Causative Mutations in 30 Different Genes.
|
27864847 |
2017 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies.
|
27476654 |
2016 |
Autism Spectrum Disorders
|
0.540 |
GeneticVariation
|
disease |
BEFREE |
Examining paternal transmissions only, we found marginal evidence for LD with a protective allele at marker D15S11 in the ASD families (Chi-sq 7 df, P = 0.05) and marginal evidence for risk alleles at markers D15S1506 (Chi-sq 13.7, 6 df, P = 0.06), GABRB3 (Chi-sq 15.9, 8 df, P = 0.11) and D15S1002 (Chi-sq 17.7, 9 df, P = 0.08) in the autism only families.
|
15952184 |
2005 |
Autism Spectrum Disorders
|
0.540 |
Biomarker
|
disease |
MGD |
|
|
|
Autism Spectrum Disorders
|
0.540 |
AlteredExpression
|
disease |
BEFREE |
The underlying mechanism of the aberrant expression of GABRB3 gene in ASD patients should be investigated in other biological levels.
|
30074174 |
2018 |
Autism Spectrum Disorders
|
0.540 |
Biomarker
|
disease |
CTD_human |
Predictive models for subtypes of autism spectrum disorder based on single-nucleotide polymorphisms and magnetic resonance imaging.
|
22037176 |
2011 |
Autism Spectrum Disorders
|
0.540 |
GeneticVariation
|
disease |
BEFREE |
Our finding suggested that single-nucleotide polymorphisms in GABRB3 may play a significant role in the genetic predisposition to ASD in the Korean population.
|
17230033 |
2006 |
Autism Spectrum Disorders
|
0.540 |
Biomarker
|
disease |
BEFREE |
Our data provide preliminary evidence that GABRB3 gene is associated with ASD in Korea.
|
19430570 |
2009 |
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
One 15q11-q13 locus encodes the GABA(A) receptor β3 subunit gene (GABRB3), which has been implicated by several studies in both autism and absence epilepsy, and the co-morbidity of epilepsy in autism is well established.
|
19935738 |
2011 |
Absence Epilepsy
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Previous studies reported that SNPs at the 5' regulatory region of GABRB3 could regulate GABRB3 gene expression and associated with childhood absence epilepsy (CAE).
|
25025424 |
2014 |
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
GABRB3 mutation, G32R, associated with childhood absence epilepsy alters α1β3γ2L γ-aminobutyric acid type A (GABAA) receptor expression and channel gating.
|
22303015 |
2012 |
Absence Epilepsy
|
0.500 |
AlteredExpression
|
disease |
LHGDN |
A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity.
|
16835263 |
2006 |
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Our study failed to replicate an association of the common GABRB3 exon 1a promoter SNP rs4906902 with CAE.
|
17215107 |
2007 |
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in GABRB3 have been increasingly recognized as a major cause for severe paediatric epilepsy syndromes such as Lennox-Gastaut syndrome, Dravet syndrome and infantile spasms with intellectual disability as well as relatively mild epilepsy syndromes such as childhood absence epilepsy.
|
31435640 |
2019 |
Absence Epilepsy
|
0.500 |
Biomarker
|
disease |
CTD_human |
Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy.
|
18514161 |
2008 |
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We screened for mutations in the GABA(A) receptor (GABAR) beta 3 subunit gene (GABRB3) in 48 probands and families with remitting CAE.
|
18514161 |
2008 |
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
LHGDN |
Mutation screening and linkage disequilibrium mapping of the gene encoding the GABA(A) beta(3) subunit (GABRB3) identified a common genetic variant in the exon 1a promoter region (C-allele of rs4906902) which displayed a reduced transcriptional activity and showed a strong allelic association with childhood absence epilepsy (CAE).
|
17215107 |
2007 |
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In a previous study of our group, an association between the GABA(A) receptor beta3 subunit (GABRB3) gene and CAE was shown.
|
16835263 |
2006 |